Evidence map›Paper›PMID 27302190›Full record

ArticleThe Journal of infectious diseases2016

Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013.

Michael D Bowen, Slavica Mijatovic-Rustempasic, Mathew D Esona, Elizabeth N Teel, Rashi Gautam, Michele Sturgeon, Parvin H Azimi, Carol J Baker, David I Bernstein, Julie A Boom and 19 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Possibilities of using mussels (Journal of veterinary research · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. The Changing Landscape of Pediatric Viral Enteropathogens in the Post-Rotavirus Vaccine Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 1 country.

Michael D BowenCenters for Disease Control and Prevention, Atlanta, Georgia.
Slavica Mijatovic-RustempasicCenters for Disease Control and Prevention, Atlanta, Georgia.
Mathew D EsonaCenters for Disease Control and Prevention, Atlanta, Georgia.
Elizabeth N TeelCenters for Disease Control and Prevention, Atlanta, Georgia.
Rashi GautamCenters for Disease Control and Prevention, Atlanta, Georgia.
Michele SturgeonCenters for Disease Control and Prevention, Atlanta, Georgia.
Parvin H AzimiUCSF Benioff Children's Hospital Oakland.
Carol J BakerTexas Children's Hospital Baylor College of Medicine, Houston, Texas.
David I BernsteinCincinnati Children's Hospital Medical Center, Ohio.
Julie A BoomTexas Children's Hospital Baylor College of Medicine, Houston, Texas.
James ChappellVanderbilt University Medical Center, Nashville, Tennessee.
Stephanie DonauerCincinnati Children's Hospital Medical Center, Ohio.
Kathryn M EdwardsVanderbilt University Medical Center, Nashville, Tennessee.
Janet A EnglundSeattle Children's Hospital, Washington.
Natasha B HalasaVanderbilt University Medical Center, Nashville, Tennessee.
Christopher J HarrisonChildren's Mercy Hospitals and Clinics, Kansas City, Missouri.
Samantha H JohnstonUCSF Benioff Children's Hospital Oakland.
Eileen J KleinSeattle Children's Hospital, Washington.
Monica M McNealCincinnati Children's Hospital Medical Center, Ohio.
Mary E MoffattChildren's Mercy Hospitals and Clinics, Kansas City, Missouri.
Marcia A RenchTexas Children's Hospital Baylor College of Medicine, Houston, Texas.
Leila C SahniTexas Children's Hospital.
Rangaraj SelvaranganChildren's Mercy Hospitals and Clinics, Kansas City, Missouri.
Mary A StaatCincinnati Children's Hospital Medical Center, Ohio.
Peter G SzilagyiUniversity of California-Los Angeles.
Geoffrey A WeinbergUniversity of Rochester School of Medicine and Dentistry, New York.
Mary E WikswoCenters for Disease Control and Prevention, Atlanta, Georgia.
Umesh D ParasharCenters for Disease Control and Prevention, Atlanta, Georgia.
Daniel C PayneCenters for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USCincinnati Children's Hospital Medical Center · USChildren's Mercy Hospital · USVanderbilt University Medical Center · USBaylor College of Medicine · USSeattle Children's Hospital · USTexas Children's Hospital · USUCSF Benioff Children's Hospital · USUniversity of California, Los Angeles · USUniversity of Rochester · US

Funding

Enhanced Surveillance for New Vaccine Preventable DiseaseU01IP000461 · IP · TEXAS CHILDREN'S HOSPITAL · PI BOOM, JULIE ANNE · 2011 to 2015
$2.7M
Intramural CDC HHS CC999999NCIRD CDC HHS U01 IP000461NCIRD CDC HHS U01 IP001049NCIRD CDC HHS U01 IP001050NCIRD CDC HHS U01 IP001059
6 · The paper itself

Abstract

backgroundGroup A rotaviruses (RVA) are a significant cause of pediatric gastroenteritis worldwide. The New Vaccine Surveillance Network (NVSN) has conducted active surveillance for RVA at pediatric hospitals and emergency departments at 3-7 geographically diverse sites in the United States since 2006.

methodsOver 6 consecutive years, from 2008 to 2013, 1523 samples from NVSN sites that were tested positive by a Rotaclone enzyme immunoassay were submitted to the Centers for Disease Control and Prevention for genotyping.

resultsIn the 2009, 2010, and 2011 seasons, genotype G3P[8] was the predominant genotype throughout the network, with a 46%-84% prevalence. In the 2012 season, G12P[8] replaced G3P[8] as the most common genotype, with a 70% prevalence, and this trend persisted in 2013 (68.0% prevalence). Vaccine (RotaTeq; Rotarix) strains were detected in 0.6%-3.4% of genotyped samples each season. Uncommon and unusual strains (eg, G8P[4], G3P[24], G2P[8], G3P[4], G3P[6], G24P[14], G4P[6], and G9P[4]) were detected sporadically over the study period. Year, study site, and race were found to be significant predictors of genotype.

conclusionsContinued active surveillance is needed to monitor RVA genotypes in the United States and to detect potential changes since vaccine licensure.

Indexed as

GenotypeChildChild, PreschoolEpidemiological MonitoringFemaleHumansInfantMaleRotavirusRotavirus InfectionsRotavirus VaccinesUnited StatesRotavirus Vaccinesgenotypeprevalencerotavirussurveillancevaccine

Identifiers

PMID27302190
PMCPMC5075963
OpenAlexW2427633769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.